{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:44:27Z","timestamp":1778658267653,"version":"3.51.4"},"publisher-location":"Cham","reference-count":70,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030590376","type":"print"},{"value":"9783030590383","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-59038-3_16","type":"book-chapter","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:06:56Z","timestamp":1624979216000},"page":"259-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sweat Gland Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Adeodatus","family":"Yuda Handaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumadi Lukman","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya Rifqi","family":"Fauzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Agastya Pramudya","family":"Werdana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"6","key":"16_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7\u201334","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"16_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/archdermatol.2010.105","volume":"146","author":"PW Blake","year":"2010","unstructured":"Blake PW, Bradford PT, Devesa SS, Toro JR (2010) Cutaneous appendageal carcinoma incidence and survival patterns in the United States: a population-based study. Arch Dermatol 146(6):625\u2013632","journal-title":"Arch Dermatol"},{"key":"16_CR4","volume-title":"Pathology and genetics of skin tumours","year":"2006","unstructured":"LeBoit PE (ed) (2006) Pathology and genetics of skin tumours, vol 6. IARC, Lyon"},{"issue":"10","key":"16_CR5","doi-asserted-by":"publisher","first-page":"e47290","DOI":"10.1371\/journal.pone.0047290","volume":"7","author":"LP Le","year":"2012","unstructured":"Le LP, Dias-Santagata D, Pawlak AC, Cosper AK, Nguyen AT, Selim MA, Deng A, Horick NK, Iafrate AJ, Mihm MC Jr, Hoang MP (2012) Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One 7(10):e47290","journal-title":"PLoS One"},{"issue":"1","key":"16_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12893-018-0421-4","volume":"18","author":"AY Handaya","year":"2018","unstructured":"Handaya AY, Budi NYP, Nugroho GMA, Fauzi AR (2018) Wide excision and reconstruction surgery for recurrent sweat gland umbilical adenocarcinoma followed by chemotherapy can prevent the risk of recurrences. BMC Surg 18(1):85","journal-title":"BMC Surg"},{"issue":"1","key":"16_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12957-018-1401-y","volume":"16","author":"T Oyasiji","year":"2018","unstructured":"Oyasiji T, Tan W, Kane J, Skitzki J, Francescutti V, Salerno K, Khushalani NI (2018) Malignant adnexal tumors of the skin: a single institution experience. World J Surg Oncol 16(1):99","journal-title":"World J Surg Oncol"},{"issue":"1","key":"16_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.canlet.2015.07.044","volume":"380","author":"Y Sun","year":"2016","unstructured":"Sun Y (2016) Tumor microenvironment and cancer therapy resistance. Cancer Lett 380(1):205\u2013215","journal-title":"Cancer Lett"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/0008-5472.CAN-12-0122","volume":"72","author":"MA Swartz","year":"2012","unstructured":"Swartz MA, Iida N, Roberts EW, Sangaletti S, Wong MH, Yull FE, Coussens LM, DeClerck YA (2012) Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 72:2473\u20132480","journal-title":"Cancer Res"},{"key":"16_CR10","first-page":"1","volume":"2019","author":"T Hu","year":"2019","unstructured":"Hu T, Xu Y, Yao B, Fu X, Huang S (2019) Developing a novel and convenient model for investigating sweat gland morphogenesis from epidermal stem cells. Stem Cells Int 2019:1\u20137","journal-title":"Stem Cells Int"},{"key":"16_CR11","first-page":"49","volume-title":"Fitzpatrick\u2019s dermatology","author":"T Fitzpatrick","year":"2019","unstructured":"Fitzpatrick T, Kang S (2019) Fitzpatrick\u2019s dermatology, 9th edn. McGraw-Hill Education, New York, pp 49\u201360","edition":"9"},{"issue":"1","key":"16_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000455091","volume":"10","author":"S Furudate","year":"2017","unstructured":"Furudate S, Fujimura T, Tsukada A, Sato Y, Hidaka T, Tanita K, Kambayashi Y, Haga T, Hashimoto A, Aiba S (2017) Successful treatment of advanced primary cutaneous apocrine carcinoma on the scrotum with systemic chemotherapy and radiotherapy followed by Denosumab. Case Rep Oncol 10(1):52\u201356","journal-title":"Case Rep Oncol"},{"issue":"3","key":"16_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<317::AID-IJC5>3.0.CO;2-Y","volume":"76","author":"W Biernat","year":"1998","unstructured":"Biernat W, Peraud A, Wozniak L, Ohgaki H (1998) P 53 mutations in sweat gland carcinomas. Int J Cancer 76(3):317\u2013320","journal-title":"Int J Cancer"},{"issue":"7","key":"16_CR14","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/modpathol.2011.48","volume":"24","author":"D Dias-Santagata","year":"2011","unstructured":"Dias-Santagata D, Lam Q, Bergethon K, Baker GM, Iafrate AJ, Rakheja D, Hoang MP (2011) A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas. Mod Pathol 24(7):974","journal-title":"Mod Pathol"},{"issue":"3","key":"16_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/DAD.0b013e3181984f10","volume":"31","author":"DV Kazakov","year":"2009","unstructured":"Kazakov DV, Ivan D, Kutzner H, Spagnolo DV, Grossmann P, Vanecek T, Sima R, Kacerovska D, Shelekhova KV, Denisjuk N, Hillen U (2009) Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2\/neu gene expression\/amplification, TP53 gene mutation analysis, and t (11; 19) translocation. Am J Dermatopathol 31(3):236\u2013247","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"16_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1034\/j.1600-0560.2000.027001030.x","volume":"27","author":"M Takata","year":"2000","unstructured":"Takata M, Hashimoto K, Mehregan P, Lee MW, Yamamoto A, Mohri S, Ohara K, Takehara K (2000) Genetic changes in sweat gland carcinomas. J Cutan Pathol 27(1):30\u201335","journal-title":"J Cutan Pathol"},{"issue":"8","key":"16_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4161\/cbt.3.8.994","volume":"3","author":"KE Bachman","year":"2004","unstructured":"Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA (2004) The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3(8):772\u2013775","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"16_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.cco.0000198021.99347.b9","volume":"18","author":"Y Samuels","year":"2006","unstructured":"Samuels Y, Ericson K (2006) Oncogenic PI3K and its role in cancer. Curr Opin Oncol 18(1):77\u201382","journal-title":"Curr Opin Oncol"},{"key":"16_CR67","doi-asserted-by":"crossref","unstructured":"Turley SJ, Cremasco V, Astarita JL. Immunological hallmarks of stromal cells in the tumour microenvironment. Nature reviews immunology. 2015;15(11):669\u201382.","DOI":"10.1038\/nri3902"},{"issue":"3","key":"16_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.suronc.2011.09.001","volume":"21","author":"CE Weber","year":"2012","unstructured":"Weber CE, Kuo PC (2012) The tumor microenvironment. Surg Oncol 21(3):172\u2013177","journal-title":"Surg Oncol"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125:5591\u20135596","journal-title":"J Cell Sci"},{"issue":"1","key":"16_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2015.07.039","volume":"368","author":"L Hui","year":"2015","unstructured":"Hui L, Chen Y (2015) Tumor microenvironment: sanctuary of the devil. Cancer Lett 368(1):7\u201313","journal-title":"Cancer Lett"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/586905","volume":"2010","author":"NE Campbell","year":"2010","unstructured":"Campbell NE, Kellenberger L, Greenaway J, Moorehead RA, Linnerth-Petrik NM, Petrik J (2010) Extracellular matrix proteins and tumor angiogenesis. J Oncol 2010:1\u201313","journal-title":"J Oncol"},{"issue":"5","key":"16_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6(5):392","journal-title":"Nat Rev Cancer"},{"issue":"7015","key":"16_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Neilson EG, Moses HL (2004) Stromal fibroblasts in cancer initiation and progression. Nature 432(7015):332","journal-title":"Nature"},{"issue":"10","key":"16_CR25","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.3390\/ijms19103028","volume":"19","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, del R\u00edo Hern\u00e1ndez A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci 19(10):3028","journal-title":"Int J Mol Sci"},{"issue":"4","key":"16_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1083\/jcb.201102147","volume":"196","author":"P Lu","year":"2012","unstructured":"Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196(4):395\u2013406","journal-title":"J Cell Biol"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/cei.13293","volume":"197","author":"YR Yu","year":"2019","unstructured":"Yu YR, Ho PC (2019) Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting. Clin Exp Immunol 197:153\u2013160","journal-title":"Clin Exp Immunol"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4273943","volume":"2016","author":"PH Pandya","year":"2016","unstructured":"Pandya PH, Murray ME, Pollok KE, Renbarger JL (2016) The immune system in cancer pathogenesis: potential therapeutic approaches. J Immunol Res 2016:1\u201313","journal-title":"J Immunol Res"},{"issue":"3","key":"16_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12307-012-0107-x","volume":"5","author":"ZY Ding","year":"2012","unstructured":"Ding ZY, Zou XL, Wei YQ (2012) Cancer microenvironment and cancer vaccine. Cancer Microenviron 5(3):333\u2013344","journal-title":"Cancer Microenviron"},{"issue":"2","key":"16_CR30","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","volume":"267","author":"A Sica","year":"2008","unstructured":"Sica A, Allavena P, Mantovani A (2008) Cancer related inflammation: the macrophage connection. Cancer Lett 267(2):204\u2013215","journal-title":"Cancer Lett"},{"issue":"11","key":"16_CR31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555","journal-title":"Trends Immunol"},{"key":"16_CR68","doi-asserted-by":"crossref","unstructured":"Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Current opinion in immunology. 2010;22(2):231-7.","DOI":"10.1016\/j.coi.2010.01.009"},{"issue":"1","key":"16_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12943-018-0913-y","volume":"17","author":"YA Wang","year":"2018","unstructured":"Wang YA, Li XL, Mo YZ, Fan CM, Tang L, Xiong F, Guo C, Xiang B, Zhou M, Ma J, Huang X (2018) Effects of tumor metabolic microenvironment on regulatory T cells. Mol Cancer 17(1):168","journal-title":"Mol Cancer"},{"key":"16_CR69","doi-asserted-by":"crossref","unstructured":"Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S. The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin. Anticancer research. 2018;38(1):113\u201320.","DOI":"10.21873\/anticanres.12198"},{"issue":"5564","key":"16_CR33","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer\u2014trials and tribulations. Science 295(5564):2387\u20132392","journal-title":"Science"},{"issue":"4","key":"16_CR34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J (2006) Cancer metastasis: building a framework. Cell 127(4):679\u2013695","journal-title":"Cell"},{"issue":"1","key":"16_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367","journal-title":"Cell"},{"issue":"3","key":"16_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37(3):208\u2013220","journal-title":"Trends Immunol"},{"issue":"5","key":"16_CR37","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/ijc.31744","volume":"144","author":"Z Yin","year":"2019","unstructured":"Yin Z, Li C, Wang J, Xue L (2019) Myeloid-derived suppressor cells: roles in the tumor microenvironment and tumor radiotherapy. Int J Cancer 144(5):933\u2013946","journal-title":"Int J Cancer"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"281261","DOI":"10.1155\/2012\/281261","volume":"2012","author":"F Fan","year":"2012","unstructured":"Fan F, Schimming A, Jaeger D, Podar K (2012) Targeting the tumor microenvironment: focus on angiogenesis. J Oncol 2012:281261","journal-title":"J Oncol"},{"issue":"4","key":"16_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/156800908784533481","volume":"8","author":"M Furuya","year":"2008","unstructured":"Furuya M, Yonemitsu Y (2008) Cancer neovascularization and proinflammatory microenvironments. Curr Cancer Drug Targets 8(4):253\u2013265","journal-title":"Curr Cancer Drug Targets"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/B978-0-323-47674-4.00008-6","volume-title":"Abeloff\u2019s clinical oncology","author":"RK Jain","year":"2020","unstructured":"Jain RK, Martin JD, Chauhan VP, Duda DG (2020) Tumor microenvironment: vascular and extravascular compartment. In: Abeloff\u2019s clinical oncology, pp 108\u2013126"},{"issue":"16","key":"16_CR41","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.2174\/138161209788453275","volume":"15","author":"M Furuya","year":"2009","unstructured":"Furuya M, Yonemitsu Y, Aoki I (2009) III. Angiogenesis: complexity of tumor vasculature and microenvironment. Curr Pharm Des 15(16):1854\u20131867","journal-title":"Curr Pharm Des"},{"issue":"1","key":"16_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","volume":"314","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Betsholtz C (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314(1):15\u201323","journal-title":"Cell Tissue Res"},{"key":"16_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/868475","volume":"2015","author":"AL Ribeiro","year":"2015","unstructured":"Ribeiro AL, Okamoto OK (2015) Combined effects of pericytes in the tumor microenvironment. Stem Cells Int 2015:1\u20138","journal-title":"Stem Cells Int"},{"issue":"1","key":"16_CR44","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1152\/ajpcell.00084.2014","volume":"307","author":"A Birbrair","year":"2014","unstructured":"Birbrair A, Zhang T, Wang ZM, Messi ML, Olson JD, Mintz A, Delbono O (2014) Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol 307(1):C25\u2013C38","journal-title":"Am J Physiol Cell Physiol"},{"issue":"24","key":"16_CR45","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","volume":"16","author":"X Lu","year":"2010","unstructured":"Lu X, Kang Y (2010) Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16(24):5928\u20135935","journal-title":"Clin Cancer Res"},{"issue":"1","key":"16_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ccr.2014.06.021","volume":"26","author":"UE Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2014) Metabolic asymmetry in cancer: a \u201cbalancing act\u201d that promotes tumor growth. Cancer Cell 26(1):5\u20137","journal-title":"Cancer Cell"},{"issue":"9","key":"16_CR47","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, Gajewski TF, Alitalo K, Eikesdal HP, Wiig H, Swartz MA (2016) Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest 126(9):3389\u20133402","journal-title":"J Clin Invest"},{"issue":"3","key":"16_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrc3186","volume":"12","author":"MA Swartz","year":"2012","unstructured":"Swartz MA, Lund AW (2012) Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12(3):210","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"16_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, \u00d6stman A (2004) High interstitial fluid pressure\u2014an obstacle in cancer therapy. Nat Rev Cancer 4(10):806","journal-title":"Nat Rev Cancer"},{"key":"16_CR50","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2217\/14796694.4.6.793","volume":"4","author":"SJ Lunt","year":"2008","unstructured":"Lunt SJ, Fyles A, Hill RP, Milosevic M (2008) Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 4:793\u2013802","journal-title":"Future Oncol"},{"key":"16_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/639058","volume":"2014","author":"SL Schlereth","year":"2014","unstructured":"Schlereth SL, Refaian N, Iden S, Cursiefen C, Heindl LM (2014) Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis. BioMed Res Int 2014:1\u201314","journal-title":"BioMed Res Int"},{"issue":"00","key":"16_CR52","first-page":"1","volume":"2020","author":"P Prazeres","year":"2020","unstructured":"Prazeres P, Leonel P, Silva WN, Rocha BG, Santos GS, Costa AC et al (2020) Ablation of sensory nerves favours melanoma progression. J Cell Mol Med 2020(00):1\u201313","journal-title":"J Cell Mol Med"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ceb.2017.05.006","volume":"48","author":"M Reina-Campos","year":"2017","unstructured":"Reina-Campos M, Moscat J, Diaz-Meco M (2017) Metabolism shapes the tumor microenvironment. Curr Opin Cell Biol 48:47\u201353","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"16_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canlet.2015.10.027","volume":"380","author":"P Chiarugi","year":"2016","unstructured":"Chiarugi P, Cirri P (2016) Metabolic exchanges within tumor microenvironment. Cancer Lett 380(1):272\u2013280","journal-title":"Cancer Lett"},{"issue":"5","key":"16_CR55","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-12-2796","volume":"73","author":"V Estrella","year":"2013","unstructured":"Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J (2013) Acidity generated by the tumor microenvironment drives local invasion. Cancer Res 73(5):1524\u20131535","journal-title":"Cancer Res"},{"issue":"1","key":"16_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370","journal-title":"Cell"},{"issue":"3","key":"16_CR57","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/hep.26413","volume":"58","author":"JU Marquardt","year":"2013","unstructured":"Marquardt JU, Fischer K, Baus K, Kashyap A, Ma S, Krupp M, Linke M, Teufel A, Zechner U, Strand D, Thorgeirsson SS (2013) Sirtuin-6\u2013dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients. Hepatology 58(3):1054\u20131064","journal-title":"Hepatology"},{"issue":"12","key":"16_CR58","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3390\/ijms18122729","volume":"18","author":"LV Yang","year":"2017","unstructured":"Yang LV (2017) Tumor microenvironment and metabolism. Int J Mol Sci 18(12):2729. https:\/\/doi.org\/10.3390\/ijms18122729. PubMed PMID: 29258182; PubMed Central PMCID: PMC5751330","journal-title":"Int J Mol Sci"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fonc.2018.00117","volume":"8","author":"S Vasseur","year":"2018","unstructured":"Vasseur S (2018) Influence of the tumor microenvironment on cancer cells metabolic reprogramming. Front Oncol 8:117","journal-title":"Front Oncol"},{"issue":"6","key":"16_CR60","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00018-011-0860-x","volume":"69","author":"JR Whitfield","year":"2012","unstructured":"Whitfield JR, Soucek L (2012) Tumor microenvironment: becoming sick of Myc. Cell Mol Life Sci 69(6):931\u2013934","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"16_CR61","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis CA, Kimmelman AC (2017) Metabolic interactions in the tumor microenvironment. Trends Cell Biol 27(11):863\u2013875","journal-title":"Trends Cell Biol"},{"issue":"5","key":"16_CR62","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M (2016) LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab 24(5):657\u2013671","journal-title":"Cell Metab"},{"issue":"7519","key":"16_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, Cline GW (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513(7519):559","journal-title":"Nature"},{"key":"16_CR64","doi-asserted-by":"crossref","unstructured":"Hask\u00f3 G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7(9):759","DOI":"10.1038\/nrd2638"},{"key":"16_CR65","doi-asserted-by":"crossref","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27\u201347","DOI":"10.1016\/j.cmet.2015.12.006"},{"key":"16_CR66","doi-asserted-by":"crossref","unstructured":"Brenn T (2015) Malignant sweat gland tumors: an update. Adv Anat Pathol 22(4):242\u2013253","DOI":"10.1097\/PAP.0000000000000075"},{"key":"16_CR70","doi-asserted-by":"crossref","unstructured":"Takata M, Morita R, Takehara K. Clonal heterogeneity in sporadic melanomas as revealed by loss\u2010of\u2010heterozygosity analysis. International journal of cancer. 2000;85(4):492\u20137.","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<492::AID-IJC8>3.0.CO;2-#"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironments in Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-59038-3_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T15:11:52Z","timestamp":1624979512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-59038-3_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030590376","9783030590383"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-59038-3_16","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"30 June 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}